Corton Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,416
Closed -$205K 289
2024
Q4
$205K Buy
+1,416
New +$219K 0.12% 263
2024
Q2
Sell
-7,943
Closed -$1.26M 624
2024
Q1
$1.26M Sell
7,943
-2,046
-20% -$326K 0.46% 14
2023
Q4
$1.57M Buy
9,989
+4,245
+74% +$651K 0.5% 12
2023
Q3
$895K Buy
5,744
+1,901
+49% +$314K 0.45% 27
2023
Q2
$636K Buy
3,843
+976
+34% +$158K 0.3% 61
2023
Q1
$444K Buy
2,867
+541
+23% +$87.4K 0.31% 84
2022
Q4
$411K Sell
2,326
-288
-11% -$49.7K 0.34% 83
2022
Q3
$427K Sell
2,614
-610
-19% -$103K 0.52% 56
2022
Q2
$572K Buy
3,224
+695
+27% +$124K 0.54% 47
2022
Q1
$448K Buy
+2,529
New +$430K 0.19% 138

Other funds holding JNJ

Corton Capital's JNJ Position: Q1 2025 in Review

Corton Capital sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 1,416 shares — an estimated $205K sold.

Corton Capital first reported a position in JNJ in Q1 2022 and held it in 10 quarters. The position peaked at $1.57M in Q4 2023. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Corton Capital reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 1,416 Johnson & Johnson shares in Q1 2025, an estimated $205K.
  • Corton Capital first reported a position in Johnson & Johnson in Q1 2022 and held it in 10 quarters.
  • Corton Capital's Johnson & Johnson position peaked at $1.57M in Q4 2023.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.